NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Arup R Chakraborty
National Institutes of Health - Bethesda / United States
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 4391548
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Arup R Chakraborty's MOST POPULAR ARTICLES
1-)
Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG …JAMA Oncology, 20181312018
2-)
Histone deacetylase inhibitors: emerging mechanisms of resistanceRW Robey, AR Chakraborty, A Basseville, V Luchenko, J Bahr, Z Zhan, ...Molecular pharmaceutics 8 (6), 2021-2031, 20111272011
3-)
SMARCA4/BRG1 is a novel prognostic biomarker predictive of cisplatin-based chemotherapy outcomes in resected non-small cell lung cancerAC Erica Hlavin Bell1,*, Arup R Chakraborty1, Xiaokui Mo2, Ziyan Liu1 ...Clinical Cancer Research, 201598*2015
4-)
MAPK pathway activation leads to Bim loss and histone deacetylase inhibitor resistance: rationale to combine romidepsin with an MEK inhibitorAR Chakraborty, RW Robey, VL Luchenko, Z Zhan, RL Piekarz, JP Gillet, ...Blood, The Journal of the American Society of Hematology 121 (20), 4115-4125, 2013922013
5-)
Circulating microRNAs in cancer: Hope or hype?CA Singh R1, Ramasubramanian B1, Kanji S1, Chakraborty AR1, Haque SJ1Cancer Letters, 2016832016
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept